autologous stem cell therapy (IntelliCell BioSciences/Invigorcell)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous stem cell therapy (IntelliCell BioSciences/Invigorcell)
Drug Alias Nameautologous stem cell therapy (IntelliCell BioSciences)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntelliCell BioSciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvigorcellIntelliCell BioSciences Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A